1. Home
  2. QNRX vs BDRX Comparison

QNRX vs BDRX Comparison

Compare QNRX & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QNRX
  • BDRX
  • Stock Information
  • Founded
  • QNRX 2018
  • BDRX 2000
  • Country
  • QNRX United States
  • BDRX United Kingdom
  • Employees
  • QNRX N/A
  • BDRX N/A
  • Industry
  • QNRX Medical/Dental Instruments
  • BDRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • QNRX Health Care
  • BDRX Health Care
  • Exchange
  • QNRX Nasdaq
  • BDRX Nasdaq
  • Market Cap
  • QNRX 5.3M
  • BDRX 2.4M
  • IPO Year
  • QNRX N/A
  • BDRX N/A
  • Fundamental
  • Price
  • QNRX $0.70
  • BDRX $4.50
  • Analyst Decision
  • QNRX Strong Buy
  • BDRX Strong Buy
  • Analyst Count
  • QNRX 1
  • BDRX 1
  • Target Price
  • QNRX $4.00
  • BDRX $200.00
  • AVG Volume (30 Days)
  • QNRX 1.4M
  • BDRX 30.1K
  • Earning Date
  • QNRX 11-07-2024
  • BDRX 01-17-2025
  • Dividend Yield
  • QNRX N/A
  • BDRX N/A
  • EPS Growth
  • QNRX N/A
  • BDRX N/A
  • EPS
  • QNRX N/A
  • BDRX N/A
  • Revenue
  • QNRX N/A
  • BDRX $104,895.00
  • Revenue This Year
  • QNRX N/A
  • BDRX N/A
  • Revenue Next Year
  • QNRX N/A
  • BDRX N/A
  • P/E Ratio
  • QNRX N/A
  • BDRX N/A
  • Revenue Growth
  • QNRX N/A
  • BDRX N/A
  • 52 Week Low
  • QNRX $0.43
  • BDRX $3.50
  • 52 Week High
  • QNRX $6.18
  • BDRX $74.00
  • Technical
  • Relative Strength Index (RSI)
  • QNRX 54.60
  • BDRX 49.64
  • Support Level
  • QNRX $0.47
  • BDRX $3.83
  • Resistance Level
  • QNRX $0.75
  • BDRX $4.73
  • Average True Range (ATR)
  • QNRX 0.10
  • BDRX 0.33
  • MACD
  • QNRX 0.01
  • BDRX 0.05
  • Stochastic Oscillator
  • QNRX 71.51
  • BDRX 75.27

About QNRX Quoin Pharmaceuticals Ltd.

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

About BDRX Biodexa Pharmaceuticals plc American Depositary Shs

Biodexa Pharmaceuticals PLC is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The company combines approved and developed medications with its proprietary and drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.

Share on Social Networks: